Kezar Life Sciences, Inc. (KZR) Misses Q2 EPS by 2c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q2 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh